Aptose Biosciences Inc Stock Price Today (NSE: APS)
Fundamental Score
Aptose Biosciences Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Aptose Biosciences Inc share price today is ₹230.05, down 0.30% on NSE/BSE as of 17 September 2026. Aptose Biosciences Inc (APS) is a Small-cap company in the Heavy Electrical Equipment sector with a market capitalisation of ₹591.59 (Cr). The 52-week high for APS share price is ₹543.95 and the 52-week low is ₹226.60. At a P/E ratio of 10.47x, APS is currently trading below its industry average P/E of 38.29x. The company has a Return on Equity (ROE) of 45.36% and a debt-to-equity ratio of 0.27.
Aptose Biosciences Inc Share Price Chart — NSE/BSE Historical Performance
Aptose Biosciences Inc share price chart: 0.04% return over the past month. 52-week high ₹543.95, 52-week low ₹226.60.
Aptose Biosciences Inc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹230.75 | ₹233.90 | ₹229.00 | ₹230.05 | 7.00K (Cr) | |
| ₹233.40 | ₹233.40 | ₹226.60 | ₹230.75 | 17.25K (Cr) | |
| ₹240.00 | ₹241.00 | ₹232.85 | ₹233.35 | 18.00K (Cr) | |
| ₹235.00 | ₹244.85 | ₹235.00 | ₹239.30 | 14.75K (Cr) | |
| ₹243.65 | ₹245.30 | ₹236.90 | ₹237.95 | 27.75K (Cr) | |
| ₹257.90 | ₹257.90 | ₹246.90 | ₹246.90 | 15.00K (Cr) | |
| ₹242.50 | ₹254.00 | ₹242.50 | ₹250.60 | 14.75K (Cr) | |
| ₹241.00 | ₹250.00 | ₹241.00 | ₹242.50 | 9.00K (Cr) | |
| ₹245.00 | ₹248.65 | ₹241.00 | ₹244.75 | 12.00K (Cr) | |
| ₹245.10 | ₹252.00 | ₹244.00 | ₹245.00 | 13.25K (Cr) |
Aptose Biosciences Inc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹252.90 | ₹257.90 | ₹226.60 | ₹230.05 | -9.04% | |
| ₹270.15 | ₹280.50 | ₹228.00 | ₹250.40 | -7.31% | |
| ₹298.00 | ₹306.95 | ₹269.25 | ₹270.95 | -9.08% | |
| ₹302.00 | ₹330.00 | ₹302.00 | ₹326.35 | +8.06% | |
| ₹372.90 | ₹374.85 | ₹328.00 | ₹329.85 | -11.54% | |
| ₹288.05 | ₹395.00 | ₹280.00 | ₹384.70 | +33.55% | |
| ₹295.00 | ₹309.80 | ₹261.00 | ₹264.50 | -10.34% | |
| ₹321.05 | ₹398.00 | ₹321.00 | ₹351.80 | +9.58% | |
| ₹366.25 | ₹371.95 | ₹300.00 | ₹323.95 | -11.55% | |
| ₹425.00 | ₹425.05 | ₹350.15 | ₹364.00 | -14.35% | |
| ₹483.50 | ₹483.50 | ₹442.30 | ₹444.35 | -8.10% | |
| ₹446.10 | ₹543.95 | ₹446.10 | ₹525.30 | +17.75% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Aptose Biosciences Inc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Aptose Biosciences Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of APS across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (45.36%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (55.94%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 10.47 vs Industry: 38.29)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (43.96%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (56.24% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (99.24% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.27)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (17.31x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (72.62%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Weak Earnings Growth (-50.03% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-55.90 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.46%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Aptose Biosciences Inc vs Heavy Electrical Equipment Peers
Peer Comparison - Heavy Electrical Equipment
Compare Aptose Biosciences Inc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
67/100 | ₹230.05₹230 | ₹591.59₹591.59 | 10.47Average 10.5 Average | 45.36%Excellent 45.36% Excellent | 55.94%Excellent 55.94% Excellent | 0.27Excellent 0.3 Excellent | 99.24%Excellent 99.24% Excellent | 56.24%Excellent 56.24% Excellent | 0.03% | |
ABB India LimitedABB India Limit... ABB • 500002 | 64.2/100 | ₹7401.50₹7402 | ₹156837.79₹156837.79 | 52.49Average 52.5 Average | 22.38%Excellent 22.38% Excellent | 29.95%Excellent 29.95% Excellent | 0.00Excellent 0.0 Excellent | 50.06%Excellent 50.06% Excellent | 17.80%Excellent 17.80% Excellent | 0.55% |
Bharat Heavy Electricals LimitedBharat Heavy El... BHEL • 500103 | 63.1/100 | ₹433.70₹434 | ₹151016.51₹151016.51 | 62.05Average 62.0 Average | 6.29%Poor 6.29% Poor | 6.77%Poor 6.77% Poor | 0.31Excellent 0.3 Excellent | 20.93%Excellent 20.93% Excellent | 14.31%Good 14.31% Good | 0.33% |
CG Power and Industrial Solutions LimitedCG Power and In... CGPOWER • 500093 | 76.1/100 | ₹926.95₹927 | ₹145994.63₹145994.63 | 116.74Average 116.7 Average | 20.42%Excellent 20.42% Excellent | 25.68%Excellent 25.68% Excellent | 0.00Excellent 0.0 Excellent | 69.51%Excellent 69.51% Excellent | 33.18%Excellent 33.18% Excellent | 0.14% |
Hitachi Energy India LimitedHitachi Energy ... POWERINDIA • 543187 | 72.8/100 | ₹31580.00₹31580 | ₹140846.80₹140846.80 | 122.36Average 122.4 Average | 21.04%Excellent 21.04% Excellent | 27.65%Excellent 27.65% Excellent | 0.00Excellent 0.0 Excellent | 53.66%Excellent 53.66% Excellent | 18.96%Excellent 18.96% Excellent | 0.02% |
Siemens LimitedSiemens Limited... SIEMENS • 500550 | 68.4/100 | ₹3949.10₹3949 | ₹140587.96₹140587.96 | 41.09Average 41.1 Average | 21.03%Excellent 21.03% Excellent | 22.16%Excellent 22.16% Excellent | 0.00Excellent 0.0 Excellent | 29.56%Excellent 29.56% Excellent | 20.09%Excellent 20.09% Excellent | 0.00% |
GE Vernova T&D India LimitedGE Vernova T&D ... GVT&D • 522275 | 72/100 | ₹4673.00₹4673 | ₹119652.16₹119652.16 | 91.66Average 91.7 Average | 55.26%Excellent 55.26% Excellent | 70.55%Excellent 70.55% Excellent | 0.00Excellent 0.0 Excellent | 82.86%Excellent 82.86% Excellent | 12.45%Good 12.45% Good | 0.21% |
Siemens Energy India LimitedSiemens Energy ... ENRIN • 544390 | 51.3/100 | ₹3183.70₹3184 | ₹113339.72₹113339.72 | 76.18Average 76.2 Average | 8.64%Poor 8.64% Poor | 9.90%Poor 9.90% Poor | 0.00Excellent 0.0 Excellent | — — | — — | 0.11% |
Suzlon Energy LimitedSuzlon Energy L... SUZLON • 532667 | 64.4/100 | ₹45.45₹45 | ₹62507.61₹62507.61 | 19.93Average 19.9 Average | 40.64%Excellent 40.64% Excellent | 32.54%Excellent 32.54% Excellent | 0.03Excellent 0.0 Excellent | 97.91%Excellent 97.91% Excellent | 37.98%Excellent 37.98% Excellent | 0.00% |
Thermax LimitedThermax Limited... THERMAX • 500411 | 50/100 | ₹3638.60₹3639 | ₹40988.83₹40988.83 | 69.10Average 69.1 Average | 13.74%Average 13.74% Average | 16.55%Good 16.55% Good | 0.41Excellent 0.4 Excellent | 28.38%Excellent 28.38% Excellent | 17.42%Excellent 17.42% Excellent | 0.31% |
Schneider Electric Infrastructure LimitedSchneider Elect... SCHNEIDER • 534139 | 50.5/100 | ₹1193.80₹1194 | ₹28543.76₹28543.76 | 155.24Average 155.2 Average | 31.81%Excellent 31.81% Excellent | 27.39%Excellent 27.39% Excellent | 0.57Good 0.6 Good | 80.08%Excellent 80.08% Excellent | 17.38%Excellent 17.38% Excellent | 0.00% |
Top Heavy Electrical Equipment Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- ABB India Limited share price156837.79 Cr
- Bharat Heavy Electricals Limited share price151016.51 Cr
- CG Power and Industrial Solutions Limited share price145994.63 Cr
- Hitachi Energy India Limited share price140846.80 Cr
- Siemens Limited share price140587.96 Cr
Aptose Biosciences Inc Quarterly Performance
Latest quarterly metrics for APS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
43.96%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
8.94%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
56.24%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
99.24%
Compounded annual net profit growth over 5 years
Aptose Biosciences Inc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for APS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Aptose Biosciences Inc Financial Statements
Annual income statement, balance sheet and cash flow for Aptose Biosciences Inc (APS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Aptose Biosciences Inc
About APS (Aptose Biosciences Inc)
Aptose Biosciences Inc (APS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Heavy Electrical Equipment sector ...with a current market capitalisation of ₹591.59 (Cr). Aptose Biosciences Inc has delivered a Return on Equity (ROE) of 45.36% and a ROCE of 55.94%. The debt-to-equity ratio stands at 0.27, reflecting the company's capital structure. Investors tracking APS share price can monitor key metrics including P/E ratio, promoter holding of 72.62%, and quarterly earnings growth.
Company Details
APS Share Price: Frequently Asked Questions
What is the current share price of Aptose Biosciences Inc?
Aptose Biosciences Inc (APS) trades at ₹230.05 on NSE. Market cap ₹591.59 (Cr). Educational data only.
What is the P/E ratio of Aptose Biosciences Inc?
Aptose Biosciences Inc has a P/E of 10.47x vs industry average 38.29x.
What is the Bull Run score for Aptose Biosciences Inc?
Aptose Biosciences Inc has a Bull Run score of 67/100 based on 25+ financial parameters.
Does Aptose Biosciences Inc pay dividends?
Aptose Biosciences Inc has a dividend yield of 0.03%. Past dividends don't guarantee future payments.
What is the ROE of Aptose Biosciences Inc?
Aptose Biosciences Inc has ROE of 45.36%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Aptose Biosciences Inc?
Aptose Biosciences Inc has debt-to-equity of 0.27.
Is Aptose Biosciences Inc a good investment?
Bull Run gives Aptose Biosciences Inc a score of 67/100. This is not investment advice — consult a SEBI-registered advisor.